DK3239177T3 - Nyt egfrviii antistof og sammensætning omfattende samme - Google Patents
Nyt egfrviii antistof og sammensætning omfattende samme Download PDFInfo
- Publication number
- DK3239177T3 DK3239177T3 DK14906712.6T DK14906712T DK3239177T3 DK 3239177 T3 DK3239177 T3 DK 3239177T3 DK 14906712 T DK14906712 T DK 14906712T DK 3239177 T3 DK3239177 T3 DK 3239177T3
- Authority
- DK
- Denmark
- Prior art keywords
- new
- same
- composition including
- egfrviii antibody
- egfrviii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2014/011381 WO2016084993A1 (ko) | 2014-11-25 | 2014-11-25 | 신규 EGFRvIII 항체 및 이를 포함하는 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3239177T3 true DK3239177T3 (da) | 2021-04-26 |
Family
ID=56074535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14906712.6T DK3239177T3 (da) | 2014-11-25 | 2014-11-25 | Nyt egfrviii antistof og sammensætning omfattende samme |
Country Status (10)
Country | Link |
---|---|
US (1) | US10597457B2 (da) |
EP (1) | EP3239177B1 (da) |
JP (1) | JP6616833B2 (da) |
CN (1) | CN107108735B (da) |
AU (1) | AU2014412643B2 (da) |
CA (1) | CA2968510C (da) |
DK (1) | DK3239177T3 (da) |
ES (1) | ES2871598T3 (da) |
PT (1) | PT3239177T (da) |
WO (1) | WO2016084993A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019114793A1 (zh) * | 2017-12-13 | 2019-06-20 | 凯惠科技发展(上海)有限公司 | 一种egfr抗体及其制备方法和应用 |
EP3753952A4 (en) * | 2017-12-13 | 2022-04-13 | XDCExplorer (Shanghai) Co., Ltd. | EGFRVIII ANTIBODY AND CONJUGATE, METHOD FOR THE PREPARATION AND USE THEREOF |
CN114014928B (zh) * | 2021-10-27 | 2023-05-12 | 南京安吉生物科技有限公司 | 抗hmmw抗体、包含该抗体的组合物、编码该抗体的核酸分子及其用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2206343C (en) * | 1994-11-28 | 2009-04-07 | Thomas Jefferson University | Reagents and processes for targeting mutant epidermal growth factor receptors |
EP1266009B1 (en) * | 2000-02-25 | 2008-12-31 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
ES2552281T3 (es) * | 2001-05-11 | 2015-11-26 | Ludwig Institute For Cancer Research Ltd. | Proteínas de unión específica y usos de las mismas |
WO2003072727A2 (en) * | 2002-02-25 | 2003-09-04 | Georgetown University | EGFRvIII SPECIFIC MONOCLONAL ANTIBODY AND EGFRvIII RIBOZYMES AND USE TO DETECT, TREAT OR PREVENT EGFRvIII ASSOCIATED CANCER |
BRPI0411852A (pt) * | 2003-06-27 | 2006-05-23 | Abgenix Inc | anticorpos dirigidos aos mutantes de deleção de receptor de fator de crescimento epidérmico e seu usos |
KR100883430B1 (ko) | 2007-06-13 | 2009-02-12 | 한국생명공학연구원 | 혈관내피성장인자 수용체를 중화하는 인간 단클론항체 및그 용도 |
US8900816B2 (en) * | 2007-07-19 | 2014-12-02 | Duke University | Assay for anti-EGFRvIII antibodies |
US9249217B2 (en) * | 2010-12-03 | 2016-02-02 | Secretary, DHHS | Bispecific EGFRvIII x CD3 antibody engaging molecules |
EP2694542A4 (en) * | 2011-04-08 | 2014-10-08 | Univ Duke | HERPES SIMPLEX VIRUS |
AU2012340174A1 (en) * | 2011-11-16 | 2014-05-29 | Amgen Inc. | Methods of treating epidermal growth factor deletion mutant VIII related disorders |
EP3030581B1 (en) * | 2013-08-07 | 2021-01-20 | Affimed GmbH | Antibody binding sites specific for egfrviii |
-
2014
- 2014-11-25 AU AU2014412643A patent/AU2014412643B2/en active Active
- 2014-11-25 ES ES14906712T patent/ES2871598T3/es active Active
- 2014-11-25 DK DK14906712.6T patent/DK3239177T3/da active
- 2014-11-25 WO PCT/KR2014/011381 patent/WO2016084993A1/ko active Application Filing
- 2014-11-25 JP JP2017528179A patent/JP6616833B2/ja active Active
- 2014-11-25 PT PT149067126T patent/PT3239177T/pt unknown
- 2014-11-25 CN CN201480084380.XA patent/CN107108735B/zh active Active
- 2014-11-25 US US15/528,753 patent/US10597457B2/en active Active
- 2014-11-25 EP EP14906712.6A patent/EP3239177B1/en active Active
- 2014-11-25 CA CA2968510A patent/CA2968510C/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2016084993A1 (ko) | 2016-06-02 |
EP3239177A4 (en) | 2018-05-02 |
JP6616833B2 (ja) | 2019-12-04 |
CN107108735A (zh) | 2017-08-29 |
AU2014412643A1 (en) | 2017-06-15 |
JP2018501783A (ja) | 2018-01-25 |
US20170327585A1 (en) | 2017-11-16 |
CN107108735B (zh) | 2021-05-04 |
US10597457B2 (en) | 2020-03-24 |
EP3239177B1 (en) | 2021-03-17 |
CA2968510A1 (en) | 2016-06-02 |
PT3239177T (pt) | 2021-05-14 |
CA2968510C (en) | 2020-11-03 |
ES2871598T3 (es) | 2021-10-29 |
EP3239177A1 (en) | 2017-11-01 |
AU2014412643B2 (en) | 2018-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1243104A1 (zh) | 抗fgfr2/3抗體及其使用方法 | |
HK1255067A1 (zh) | 抗c10orf54抗體及其用途 | |
HK1243440A1 (zh) | 抗白細胞介素-33抗體及其用途 | |
SG10201912199XA (en) | Anti-tim-3 antibodies and use thereof | |
DK3443009T3 (da) | Anti-tim-3-antistoffer og sammensætninger | |
DK3149042T3 (da) | PD-L1-antistoffer og anvendelser deraf | |
DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
DK3350220T3 (da) | Anti-pro/latente-myostatin-antistoffer og anvendelser deraf | |
KR20180084817A (ko) | 항-siglec-9 항체 및 이의 이용 방법 | |
DK3191135T3 (da) | Anti-HER2-antistoffer og immunokonjugater | |
EP3541840C0 (en) | ANTI-HLA-G ANTIBODIES AND THEIR USE | |
GB201403875D0 (en) | Novel antibodies and uses thereof | |
GB201413913D0 (en) | Novel antibodies and uses thereof | |
DK3316909T3 (da) | Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder | |
DK3113797T3 (da) | Antistoffer, anvendelser og fremgangsmåder | |
DK3532499T3 (da) | ANTI-IL-33-antistoffer og anvendelser deraf | |
IL251837A0 (en) | Anti-endoglin antibodies and their uses | |
DK3402821T3 (da) | Psma-bindende antistof og anvendelser deraf | |
IL247315B (en) | Anti-acth antibodies and their uses | |
IL251001A0 (en) | Anti-il-25 antibodies and their uses | |
IL263242A (en) | Cytosol-penetrating antibody and use thereof | |
DK3110447T3 (da) | Anti-EGFR-antistof og anvendelser heraf | |
EP3241844A4 (en) | Antibody against neuropilin 1 and use thereof | |
DK3239177T3 (da) | Nyt egfrviii antistof og sammensætning omfattende samme | |
FR3030715B1 (fr) | Etui d'allumeur |